wsj.com
May 22, 2008
The prognosis for Sen. Ted Kennedy, who was diagnosed yesterday with a malignant glioma, isn’t good. But research into this relatively common form of brain cancer is showing new possibilities for treating the disease. A wave of cancer drugs that target a molecule called VEGF appears especially...
[read full story]